Effects of ketamine on brain function during smooth pursuit eye movements

The uncompetitive NMDA receptor antagonist ketamine has been proposed to model symptoms of psychosis. Smooth pursuit eye movements (SPEM) are an established biomarker of schizophrenia. SPEM performance has been shown to be impaired in the schizophrenia spectrum and during ketamine administration in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hum Brain Mapp
Egile Nagusiak: Steffens, M., Becker, B., Neumann, C., Kasparbauer, A.M., Meyhöfer, I., Weber, B., Mehta, M.A., Hurlemann, R., Ettinger, U.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2016
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6867533/
https://ncbi.nlm.nih.gov/pubmed/27342447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.23294
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak